Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|January 21, 2022
Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL CohortAlessandro Lazzaro, Elio Gentilini Cacciola, Cristian Borrazzo, et al.
International Journal of Molecular Sciences|January 21, 2022
The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative ReviewAlessandro Lazzaro, Gabriella De Girolamo, Valeria Filippi, et al.
AIDS Research and Human Retroviruses|July 31, 2023
MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral SuppressionDaniele Di Carlo, Francesca Falasca, Laura Mazzuti, et al.
Research Square|September 11, 2023
Antiretroviral treatment is less effective at reducing gut microbiome-associated inflammation and T cell activation in people living with HIV in rural versus urban ZimbabweAlessandro Lazzaro, Angela Sofia Burkhart Colorado, Charles Preston Neff, et al.
Viruses|June 28, 2023
Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL CohortAlessandro Lazzaro, Diana Bianchini, Elio Gentilini Cacciola, et al.
Microbiome|February 3, 2024
Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban ZimbabweAngela Sofia Burkhart Colorado, Alessandro Lazzaro, Charles Preston Neff, et al.
American Journal of Otolaryngology|August 21, 2022
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot studyPaolo Junior Fantozzi, Emanuele Pampena, Alessandra Pierangeli, et al.
Frontiers in Nutrition|January 31, 2022
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 PatientsLetizia Santinelli, Luca Laghi, Giuseppe Pietro Innocenti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2024
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical TrialAlessandro Lazzaro, Daniela Vai, Ambra Barco, et al.
Biomedicines|July 27, 2022
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of MethylprednisoloneAlessandro Russo, Chiara Davoli, Cristian Borrazzo, et al.
Pageof 3